Hackl visiting Professorship and

Special Neurology Grand Rounds

Kinne Auditorium

Monday October 3, 2016 at 12:15 PM

Video-conferenced to Nemours 1 North & Mayo Clinic Health System in Waycross

Dr. James Grotta presents:

“Development of the First U.S. Mobile Stroke Unit”

at Neurology Grand Rounds 12:15 PM on October 3, 2016

**Lunch will be provided**

Dr. James Grotta received his education at Dartmouth College and his medical training at the Universities of Virginia and Colorado, and at Massachusetts General Hospital before joining the faculty at UT-Houston in 1979.  He also spent two years in the U.S. Public Health Service (Indian Health Service).

Dr. Grotta has devoted over 35 years to preclinical and clinical research in acute stroke therapy. Most of this research has been funded by NINDS, including a series of R01 awards for pre-clinical study of calcium metabolism in rodent stroke models. His clinical research experience has included human studies of cerebral blood flow and metabolism, drug discovery, and participation and leadership of Phase I-III clinical trials in cytoprotection and reperfusion. He recently was PI or Co-PI of three promising strategies to augment the effects of tPA using hypothermia, the direct thrombin inhibitor Argatroban, and Ultrasound, all arising from his projects within the Houston Specialized Program Of Translational Research in Acute Stroke (SPOTRIAS). A consistent theme throughout his research has been his insistence on early treatment which stems from his animal modeling experience and experience in the NINDS study which clearly demonstrated the importance of ultra-early treatment to achieve maximal benefit. Consistent with this philosophy, Dr Grotta has recently launched, and personally staffs, the first Mobile Stroke Unit in the U.S. to deliver acute stroke treatment in the pre-hospital environment. Dr Grotta’s research has consistently focused on the potential of combination therapy to achieve maximal clinical benefit—combining neuroprotective strategies such as caffeine and ethanol (caffeinol), combining neuroprotection and reperfusion (ICTUS with Dr Lyden), and combining thrombolysis and anticoagulation (ARTSS, and now MOST).

**There will be a Mobile Stroke Unit (MSU) on display on campus September 28^th to all staff who are interested.

**Dr. Grotta and the MSU will be on display September 29^th – October 1^st at the 8^th annual Mayo Clinic Stoke and Cerebrovascular CME conference at Amelia Island, Ritz Carlton link.

HACKL NAMED VISITING PROFESSORSHIP

Honoring Generosity and Commitment

The Hackl Family Visiting Professorship is an important and ongoing educational event presented annually to physicians, medical students and allied health staff. It is made possible by the generous philanthropy of Albert J. and Christine M. Hackl. Mr. and Mrs. Hackl established the Hackl Family Visiting Professorship with their very first gift to Mayo Clinic in 1998. Over the next ten years, their partnership with Mayo Clinic flourished through significant contributions directed to a variety of programs and

initiatives at our Florida campus. These include the construction of our new hospital, completed in April 2008, and ongoing support for our Humanities in Medicine Program and Clinical Research in Women’s Health.

The Hackl’s and their family members have entrusted their health care to Mayo Clinic for many years. Mr. Hackl is the retired chair of the board of Herff Jones, Inc., a manufacturer of recognition awards and graduation-related products for the educational market, and Mrs. Hackl is an artist. They reside in Indianapolis, Indiana, and in Lake Wales, Florida.

Mayo Clinic continues to be grateful to the Hackl family for generously supporting the      advancement of medical education. They have built a legacy of philanthropy and progress at our Florida campus that will sustain our patients

Learning Objectives:

Define areas of new neuroscience knowledge and research

Understand Clinicopathologic (CPC) correlations of neurologic disease

Illuminate areas of practice-based improvement within the neurosciences based on advancing scientific research or Practice-based improvement projects.

The speaker does not have a relevant financial relationship, and does not intend to discuss off label/investigative use of a commercial product or device.

College of Medicine, Mayo Clinic, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

College of Medicine, Mayo Clinic, designates this live CME activity for a maximum of 1.0 AMA PRA Category 1 Credits^RM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is supported in part by an educational grant from the following companies in accordance with ACCME Standards:  NONE